Raffles Medical Group posts SGD14.4m Q2 profit. Raffles Medical recorded a 15.9% y-o-y increase in 2Q13 PATMI to SGD14.4m, as revenue grew 12.9% y-o-y to SGD86.8m. The results were within our expectations. Increased revenue intensity as well as higher charges for some services contributed to better margins. Its hospital extension is progressing on track and expected to complete end 2015. RFMD continues to focus on expanding its services, although our view is the growth would be limited by existing capacity. Our TP of SGD3.30 is based on DCF (OSK-DMG)
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....